Mochida Pharmaceutical Co., Ltd.

TSE:4534.T

3260 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 4,5479,04414,59111,9006,27311,64212,11611,58312,09711,14115,80614,06115,1198,15515,78313,72714,15310,2828,8644,032
Depreciation & Amortization 2,8082,6722,6892,7422,7312,9172,6182,7342,7643,0062,7412,8612,9322,8662,8282,6832,8103,0823,3933,501
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -15,1402,173-3,527-2,306-1252,361-4,846-2,2672,005-2,246-650287-233-1,3664441,322-5,156-1,384-2,9851,872
Accounts Receivables -7,0323,869-2,486-7408902,429-976-4,594-1971,980-197-1,97400000000
Inventory -5,873-1,277-5212,466-428362-3,743-3,444970-2,230-2,172-1,017-2,75385780017-2,595-1,292-733-487
Accounts Payables 2,225-1,9412,176-3,934192-3,032-5595,8021,01100000000000
Other Working Capital -4,4601,522-2,696-98-7792,602-1,1031,1771,035-161,5221,3042,520-2,223-3561,305-2,561-92-2,2522,359
Other Non Cash Items 16,601-6,592-6,294-3,138468-4,355-6,605-6,467-1,655-6,779-5,419-5,300-9,112-2,594-6,838-7,124-6,222-5,029-826-3,272
Operating Cash Flow -7,4807,2977,4599,1989,34712,5653,2835,58315,2115,12212,47811,9098,7067,06112,21710,6085,5856,9518,4466,133
Investing Activities:
Investments In Property Plant And Equipment -2,296-2,166-3,096-2,088-1,958-1,368-1,095-1,106-1,827-1,930-2,435-2,043-1,508-2,458-1,901-3,874-1,588-1,982-1,310-4,947
Acquisitions Net 5600204185071000000000001,98201,050
Purchases Of Investments -22,800-22,500-21,940-22,500-23,500-23,500-24,500-25,500-27,800-10,020-9,020-6,720000-1,0980-3,195-5,349-500
Sales Maturities Of Investments 25,10121,40023,03823,50023,50723,96324,50024,75014,05410,0207,0206,720001,17003,2823,0001,2514,798
Other Investing Activites 11317-946-21666921-3-237679254523931,556-1,183-4,664-318-2,271
Investing Cash Flow 74-2,949-2,007-880-1,760-1,121-426-1,835-15,576-1,953-4,359-1,964-1,254-1,935-638-3,416511-4,859-5,726-1,870
Financing Activities:
Debt Repayment 0000000-5000-375-375-375-375-1,500-600-600-600-600-6000
Common Stock Issued 00000000011811214900-200-4,0000
Common Stock Repurchased -3,492-3,512-2,511-2,008-1,990-2,523-15-16-33-1,500-2,863-804-3,653-3,421-2,313-4,134-4,643-2,766-687-3,079
Dividends Paid -2,887-3,372-3,445-3,103-3,338-3,525-3,422-2,726-2,826-3,359-2,796-2,895-2,325-2,775-2,623-2,518-2,367-1,668-1,126-1,272
Other Financing Activities -14-3,512-2,511-1-1,990-46-46-49-58-55-56-56-532,959-34-5-1-1-17,499
Financing Cash Flow -6,393-6,884-5,956-5,112-5,328-6,094-3,483-3,291-2,917-5,288-6,089-4,122-6,395-4,716-5,521-7,257-7,611-5,235-6,4143,148
Other Information:
Effect Of Forex Changes On Cash 793231-90000-21000-1-1-1-1000
Net Change In Cash 8,780-2,505-4723,1962,2595,350-626457-3,284-2,1182,0305,8231,0574096,057-66-1,516-3,143-3,6947,411
Cash At End Of Period 33,29038,01040,51540,98737,79135,53230,18230,80830,35133,63535,75333,72327,90026,84326,43420,37720,44321,95925,10228,796